Hyderabad vaccine maker to purchase CpG 1018 adjuvant from Dynavax for use in the commercial production of Biological E’s Covid-19 vaccine candidate Corbevax
The phase III clinical study to be conducted in 15 sites across India will evaluate the immunogenicity and safety of the SARS-CoV-2 Covid-19 vaccine for protection against the disease
